methyllycaconitine has been researched along with tetrabenazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooks, PA; Dwoskin, LP; Grinevich, VP; Miller, DK; Norrholm, SD; Zheng, G | 1 |
| Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Horton, DB; Nickell, JR; Siripurapu, KB; Vartak, A | 1 |
2 other study(ies) available for methyllycaconitine and tetrabenazine
| Article | Year |
|---|---|
Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Topics: Aconitine; Animals; Biological Transport; Carrier Proteins; Cells, Cultured; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ganglionic Stimulants; Humans; Iodine Radioisotopes; Kinetics; Lobeline; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Nicotine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Rubidium; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2004 |
The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Cell Membrane; Conditioning, Operant; Corpus Striatum; Dopamine; Drug Tolerance; Lobeline; Male; Methamphetamine; Nicotine; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |